| Original language | English (US) |
|---|---|
| Pages (from-to) | 1730-1731 |
| Number of pages | 2 |
| Journal | Nature medicine |
| Volume | 28 |
| Issue number | 9 |
| DOIs | |
| State | Published - Sep 2022 |
ASJC Scopus subject areas
- General Biochemistry, Genetics and Molecular Biology
Access to Document
Other files and links
Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS
In: Nature medicine, Vol. 28, No. 9, 09.2022, p. 1730-1731.
Research output: Contribution to journal › Letter › peer-review
}
TY - JOUR
T1 - Diversity, equity and inclusion actions from the NCATS Clinical and Translational Science awarded programs
AU - Boulware, L. Ebony
AU - Vitale, Alfred
AU - Ruiz, Raquel
AU - Corbie, Giselle
AU - Aguilar-Gaxiola, Sergio
AU - Wilkins, Consuelo H.
AU - Egede, Leonard E.
N1 - Funding Information: The authors would like to acknowledge K. L. Grabowski, S. McIntosh, J. Attia, J. Duong, G. Dave, M. Nunez-Smith, J. Tsevat, K. Johnson, S. Philips, L. Michener, L. Cottler, O. Carrasquillo, S. Miller-Hughes and K. Brandert for their contributions to this work. This work was funded in part by the University of Rochester Center for Leading Innovation and Collaboration (CLIC), under grant U24TR002260, UL1TR002553—Duke Clinical and Translational Science Institute (L.E.B.); UL1TR002489—North Carolina Translational and Clinical Science Institute (G.C.); UL1TR001860 UC Davis Clinical and Translational Science Center (S.A.-G.); UL1TR002243—Vanderbilt Institute for Clinical and Translational Research (C.H.W.); and UL1TR001436 and KL2TR001438, Clinical and Translational Science Institute of Southeast Wisconsin (L.E.E.). This work is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. Funding Information: The authors would like to acknowledge K. L. Grabowski, S. McIntosh, J. Attia, J. Duong, G. Dave, M. Nunez-Smith, J. Tsevat, K. Johnson, S. Philips, L. Michener, L. Cottler, O. Carrasquillo, S. Miller-Hughes and K. Brandert for their contributions to this work. This work was funded in part by the University of Rochester Center for Leading Innovation and Collaboration (CLIC), under grant U24TR002260, UL1TR002553—Duke Clinical and Translational Science Institute (L.E.B.); UL1TR002489—North Carolina Translational and Clinical Science Institute (G.C.); UL1TR001860 UC Davis Clinical and Translational Science Center (S.A.-G.); UL1TR002243—Vanderbilt Institute for Clinical and Translational Research (C.H.W.); and UL1TR001436 and KL2TR001438, Clinical and Translational Science Institute of Southeast Wisconsin (L.E.E.). This work is solely the responsibility of the authors and does not necessarily represent the official views of the NIH2.
PY - 2022/9
Y1 - 2022/9
UR - http://www.scopus.com/inward/record.url?scp=85132859839&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85132859839&partnerID=8YFLogxK
U2 - 10.1038/s41591-022-01863-7
DO - 10.1038/s41591-022-01863-7
M3 - Letter
C2 - 35764682
AN - SCOPUS:85132859839
SN - 1078-8956
VL - 28
SP - 1730
EP - 1731
JO - Nature medicine
JF - Nature medicine
IS - 9
ER -